These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2371271)

  • 1. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
    Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIOx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling.
    Turteltaub KW; Vogel JS; Frantz C; Felton JS; McManus M
    Princess Takamatsu Symp; 1995; 23():93-102. PubMed ID: 8844800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response studies of MeIQx in rat liver and liver DNA at low doses.
    Frantz CE; Bangerter C; Fultz E; Mayer KM; Vogel JS; Turteltaub KW
    Carcinogenesis; 1995 Feb; 16(2):367-73. PubMed ID: 7859370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
    Dingley KH; Roberts ML; Velsko CA; Turteltaub KW
    Chem Res Toxicol; 1998 Oct; 11(10):1217-22. PubMed ID: 9778319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzene metabolism in rodents at doses relevant to human exposure from urban air.
    Turteltaub KW; Mani C
    Res Rep Health Eff Inst; 2003 Feb; (113):1-26; discussion 27-35. PubMed ID: 12675491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin.
    Lynch AM; Murray S; Zhao K; Gooderham NJ; Boobis AR; Davies DS
    Carcinogenesis; 1993 Feb; 14(2):191-4. PubMed ID: 8435859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level biological dosimetry of heterocyclic amine carcinogens isolated from cooked food.
    Turteltaub KW; Vogel JS; Frantz C; Buonarati MH; Felton JS
    Environ Health Perspect; 1993 Mar; 99():183-6. PubMed ID: 8319619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MeIQx-DNA adduct formation in rodent and human tissues at low doses.
    Turteltaub KW; Mauthe RJ; Dingley KH; Vogel JS; Frantz CE; Garner RC; Shen N
    Mutat Res; 1997 May; 376(1-2):243-52. PubMed ID: 9202761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
    Turteltaub KW; Vogel JS; Frantz CE; Fultz E
    IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
    Brown K; Tompkins EM; White IN
    Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
    Dingley KH; Freeman SP; Nelson DO; Garner RC; Turteltaub KW
    Drug Metab Dispos; 1998 Aug; 26(8):825-8. PubMed ID: 9698300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerator mass spectrometry.
    Hellborg R; Skog G
    Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice.
    Creek MR; Mani C; Vogel JS; Turteltaub KW
    Carcinogenesis; 1997 Dec; 18(12):2421-7. PubMed ID: 9450490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA isolation and sample preparation for quantification of adduct levels by accelerator mass spectrometry.
    Dingley KH; Ubick EA; Vogel JS; Haack KW
    Methods Mol Biol; 2005; 291():21-7. PubMed ID: 15502208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification.
    Turteltaub KW; Dingley KH
    Toxicol Lett; 1998 Dec; 102-103():435-9. PubMed ID: 10022292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA dosimetry following carcinogen exposure using accelerator mass spectrometry and 32P-postlabeling.
    Felton JS; Turteltaub KW; Gledhill BL; Vogel JS; Buonarati MH; Davis JC
    Prog Clin Biol Res; 1991; 372():243-53. PubMed ID: 1956922
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerator mass spectrometry analyses of environmental radionuclides: sensitivity, precision and standardisation.
    Hotchkis M; Fink D; Tuniz C; Vogt S
    Appl Radiat Isot; 2000 Jul; 53(1-2):31-7. PubMed ID: 10879834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K; Randerath E; Agrawal HP; Gupta RC; Schurdak ME; Reddy MV
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.